ICU Medical director Greenberg proposes 883-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
David C. Greenberg, a director of ICU Medical, Inc. (ICUI), gave notice of a proposed sale of 883 common shares, with an approximate sale date of November 20, 2026. The securities table lists an aggregate market value of $155,513.96. Greenberg acquired 883 shares on November 20, 2026, through an exercise of options under a registered plan, with cash payment.
Key Figures
Key Terms
Aggregate Market Value financial
Registered Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.